These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 603758)

  • 1. Comparison of heparin and a semi-synthetic heparin analogue, A73025. II. Some effects on platelet function.
    Michalski R; Lane DA; Kakkar VV
    Br J Haematol; 1977 Oct; 37(2):247-56. PubMed ID: 603758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of heparin and a semi-synthetic heparin analogue, A73025. I. Kinetics of clearance from the circulation of man following intravenous injection.
    Lane DA; Michalski R; Van Ross ME; Kakkar VV
    Br J Haematol; 1977 Oct; 37(2):239-45. PubMed ID: 603757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of low-molecular-weight heparin on platelets as compared with commercial heparin.
    Cella G; Scattolo N; Luzzatto G; Girolami A
    Res Exp Med (Berl); 1984; 184(4):227-9. PubMed ID: 6494594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fusaric acid, a mycotoxin, and its influence on blood coagulation and platelet function.
    Devaraja S; Girish KS; Santhosh MS; Hemshekhar M; Nayaka SC; Kemparaju K
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):419-23. PubMed ID: 23343693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
    Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
    J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies.
    Vinazzer H; Woler M
    Thromb Res; 1985 Oct; 40(2):135-46. PubMed ID: 3878009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
    ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
    Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of low molecular weight heparin and unfractionated heparin on activation of human platelets in vitro.
    Westwick J; Scully MF; Poll C; Kakkar VV
    Thromb Res; 1986 May; 42(4):435-47. PubMed ID: 3715810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of heparin on the aggregation function of thrombocytes].
    Zhukovskaia ES; Blindar' VN
    Farmakol Toksikol; 1984; 47(5):36-40. PubMed ID: 6500033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observations on human platelet aggregation in native whole blood: synergism and sensitivity to aggregating agents in vitro.
    Boyd DG; Davis RB
    Thromb Res; 1988 May; 50(3):429-36. PubMed ID: 3394122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis.
    Han P; Ardlie NG
    Br J Haematol; 1974 Jun; 27(2):253-72. PubMed ID: 4843673
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of heparin and alpha 1-acid glycoprotein on thrombin or Activated Thrombofax Reagent-induced platelet aggregation and clot formation.
    Fiedel BA; Costello M; Gewurz H; Hussissian E
    Haemostasis; 1983; 13(2):89-95. PubMed ID: 6873753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
    Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
    Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
    Cofrancesco E; Colombi M; Gianese F; Cortellaro M
    Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro.
    Haaland HD; Holmsen H
    Platelets; 2011; 22(5):328-37. PubMed ID: 21388249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoassay of human platelet factor 4(PF4, antiheparin factor) by radial immunodiffusion.
    Niewiarowski S; Lowery CT; Hawiger J; Millman M; Timmons S
    J Lab Clin Med; 1976 Apr; 87(4):720-33. PubMed ID: 818325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.
    Lages B; Weiss HJ
    Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal and low molecular weight heparins: interaction with human platelets.
    Fabris F; Fussi F; Casonato A; Visentin L; Randi M; Smith MR; Girolami A
    Eur J Clin Invest; 1983 Apr; 13(2):135-9. PubMed ID: 6223824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.